RT Journal Article
SR Electronic
T1 COVID-19 Pandemic Prediction for Hungary; a Hybrid Machine Learning Approach
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.05.02.20088427
DO 10.1101/2020.05.02.20088427
A1 Pinter, Gergo
A1 Felde, Imre
A1 Mosavi, Amir
A1 Ghamisi, Pedram
A1 Gloaguen, Richard
YR 2020
UL http://medrxiv.org/content/early/2020/05/06/2020.05.02.20088427.abstract
AB Several epidemiological models are being used around the world to project the number of infected individuals and the mortality rates of the COVID-19 outbreak. Advancing accurate prediction models is of utmost importance to take proper actions. Due to a high level of uncertainty or even lack of essential data, the standard epidemiological models have been challenged regarding the delivery of higher accuracy for long-term prediction. As an alternative to the susceptible-infected-resistant (SIR)-based models, this study proposes a hybrid machine learning approach to predict the COVID-19 and we exemplify its potential using data from Hungary. The hybrid machine learning methods of adaptive network-based fuzzy inference system (ANFIS) and multi-layered perceptron-imperialist competitive algorithm (MLP-ICA) are used to predict time series of infected individuals and mortality rate. The models predict that by late May, the outbreak and the total morality will drop substantially. The validation is performed for nine days with promising results, which confirms the model accuracy. It is expected that the model maintains its accuracy as long as no significant interruption occurs. Based on the results reported here, and due to the complex nature of the COVID-19 outbreak and variation in its behavior from nation-to-nation, this study suggests machine learning as an effective tool to model the outbreak. This paper provides an initial benchmarking to demonstrate the potential of machine learning for future research.Competing Interest StatementThe authors have declared no competing interest.Funding StatementWe acknowledge the financial support of this work by the Hungarian State and the European Union under the EFOP-3.6.1-16-2016-00010 project and the 2017-1.3.1-VKE-2017-00025 project.Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData is online from WHO